GW Pharmaceuticals is Looking to Treat Autism with Cannabis

The Marijuana Times
By Julia GranowiczOct 2, 2019, 11:25 am219 pts
A few years ago, GW Pharmaceuticals aimed to have the first Food and Drug Administration (FDA) approved cannabis-based medicine to treat people with rare types of epilepsy. After years of clinical trials, they realized this goal in the summer of 2018 when the FDA approved Epidiolex, their CBD-based medicine.…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Massachusetts Marijuana Regulators Plan To Release Social Consumption Rules Proposal Next Month 69

West Virginia Emergency Town Hall: Patient Advocates Convene to Address Urgent Threat to Federal Medical Cannabis Protections 37

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.